Drug intelligence / Profile preview

clobetasol propionate + ketoconazole

Development stage
Unknown
Lead developer
J. Molner AS
Modality
Small Molecules
Administration
Topical
01

Overview

**Clobetasol propionate + ketoconazole** is a fixed-dose combination topical medication used primarily for the treatment of inflammatory skin conditions complicated by fungal infections. Clobetasol propionate is a potent synthetic corticosteroid that acts as an anti-inflammatory agent by binding to the glucocorticoid receptor, inhibiting pro-inflammatory signals and promoting anti-inflammatory gene expression, leading to reduced swelling, redness, itching, and rashes[1][5]. Ketoconazole is an imidazole antifungal agent that inhibits lanosterol 14-alpha demethylase (a cytochrome P450 enzyme), blocking ergosterol synthesis in fungal cell membranes and increasing membrane permeability, thereby preventing fungal growth[3][8]. This combination targets both inflammation (from steroid-responsive dermatoses such as eczema or psoriasis) and secondary or coexisting superficial fungal infections.

Brand names
ClobexClodanDermovateImpekloImpoyzOluxTemovateTovetNizoral A-DExtinaKetodanKuric
Other names
clobetasol topical + ketoconazole topical
02

Targets

CYP3A4 (Cytochrome P450 3A4)CYP51A1 (Sterol 14α-demethylase)GR (Glucocorticoid receptor)CYP3A5 (Cytochrome P450 family 3 subfamily A member 5)

Beyond the preview

Go deeper on clobetasol propionate + ketoconazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clobetasol propionate + ketoconazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call